» Authors » Charles Van Praet

Charles Van Praet

Explore the profile of Charles Van Praet including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 64
Citations 344
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Afferi L, Gallioli A, Territo A, Cannoletta D, Mestdagh K, Vangeneugden J, et al.
BJU Int . 2025 Mar; PMID: 40066829
Objective: To compare functional and surgical outcomes of robot-assisted ileal ureter replacement (RAIUR) vs robot-assisted kidney autotransplantation (RAKAT). Patients And Methods: This was a retrospective analysis of patients who underwent...
2.
Verghote F, Rammant E, Dirix P, Van Praet C, Berghen C, Junius S, et al.
Eur Urol Focus . 2025 Feb; PMID: 39971695
Background And Objective: Patients with muscle-invasive bladder cancer (MIBC) who develop a recurrence after radical cystectomy (RC) have poor outcomes. This study aims to evaluate the safety and efficacy of...
3.
Eggermont L, Lumen N, Van Praet C, Delanghe J, Rottey S, Vermassen T
Biochim Biophys Acta Rev Cancer . 2024 Dec; 1880(1):189239. PMID: 39672278
Alterations in the prostate cancer (PCa) N-glycome have gained attention as a potential biomarker. This comprehensive review explores the diversity of N-glycosylation patterns observed in PCa-related cell lines, tissue, serum...
4.
Rautiola J, Martini A, Mertens L, Skokic V, Di Gianfrancesco L, Bravi C, et al.
World J Urol . 2024 Nov; 42(1):617. PMID: 39487863
Purpose: To investigate functional, oncological and complication outcomes in women undergoing robot-assisted cystectomy (RARC) with intracorporeal orthotopic neobladder. Methods: From a multi-institutional database, we identified females with bladder cancer treated...
5.
De Maeseneer D, De Visschere P, Van den Broecke M, Delbare F, Villeirs G, Verbeke S, et al.
BMC Med Imaging . 2024 Oct; 24(1):268. PMID: 39375642
Background: Muscle invasive bladder cancer (MIBC) treatment combines systemic therapy and radical cystectomy (RC) or local (chemo-)radiotherapy. Response to systemic therapy is an important outcome predictor but is difficult to...
6.
Franco A, Tailly T, Berquin C, De Maeseneer D, Decruyenaere A, Verbeke S, et al.
Clin Genitourin Cancer . 2024 Sep; 22(6):102202. PMID: 39288545
Medullary sponge kidney (MSK) is an uncommon kidney malformation, characterized by cystic dilatation of the precalyceal papillary collecting ducts. Urography and computed tomography scan represent the gold standard to detect...
7.
Shuch B, Pantuck A, Bernhard J, Morris M, Master V, Scott A, et al.
Lancet Oncol . 2024 Sep; 25(10):1277-1287. PMID: 39270701
Background: With limitations of conventional imaging and biopsy, accurate, non-invasive techniques to detect clear-cell renal cell carcinoma in patients with renal masses remain an unmet need. Zr-labelled monoclonal antibody ([Zr]Zr-girentuximab)...
8.
Vanneste B, Skouteris B, Pinheiro L, Voncken R, Van Limbergen E, Lutgens L, et al.
J Contemp Brachytherapy . 2024 May; 16(2):139-149. PMID: 38808209
Purpose: To develop an approach to the diagnosis and treatment of prostate cancer using one platform for fusion biopsy, followed by focal gland ablation utilizing permanent prostate brachytherapy with and...
9.
Vermassen T, Lumen N, Van Praet C, Callewaert N, Delanghe J, Rottey S
Biomedicines . 2024 May; 12(5). PMID: 38791001
Next to prostate-specific antigen, no biochemical biomarkers have been implemented to guide patient follow-up after primary therapy for localized prostate cancer (PCa). We evaluated the prognostic potential of urine -glycome...
10.
Hofman J, De Backer P, Manghi I, Simoens J, De Groote R, Van Den Bossche H, et al.
Healthc Technol Lett . 2024 Apr; 11(2-3):33-39. PMID: 38638494
The integration of Augmented Reality (AR) into daily surgical practice is withheld by the correct registration of pre-operative data. This includes intelligent 3D model superposition whilst simultaneously handling real and...